Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-α from mast cells. Involvement of mast cells and langerhans cells in susceptibility to ultraviolet B

Journal of Investigative Dermatology

Volumn 113, Issue 6, 1999, Pages 983-990

  Alard, Pascale ^a   Niizeki, Hironori ^a   Hanninen, Laila ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Dendritic cells; Inflammatory mediators; Skin

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; HAPTEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; INFLAMMATION; LANGERHANS CELL; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

EID: 0033384974     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00772.x     Document Type: Article

References (35)

1. Applegate LA, Ley RD, Alcalay J, Kripke ML: Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J Exp Med 170:1117-1131, 1989
2. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A: The protooncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88-89, 1988
3. Dai R, Streilein JW: Sensitizing capacity of Langerhans' cells obtained from ultraviolet-B-exposed murine skin. Immunology 86:661-667, 1995
4. Dai R, Streilein JW: Ultraviolet B-exposed and soluble factor-pre-incubated epidermal Langerhans cells fail to induce contact hypersensitivity and promote DNP-specific tolerance. J Invest Dermatol 108:721-726, 1997
5. De Kossodo S, Cruz PD, Dougherty I, Thompson P, MS-V, BB: Expression of the tumor necrosis factor gene by dermal fibroblasts in response to ultraviolet irradiation or lipopolysaccharide. J Invest Dermatol 104:318-322, 1995
6. Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J: Induction of hapten-specific tolerance by interlexikin 10 in vivo. J Exp Med 179:1397-1402, 1994
7. Galli SJ, Hammel I: Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226:710-713, 1984
8. Galli SJ, Tsai M, Gordon JR, Geissler EN, Wershil BK: Analyzing mast cell development and function using mice carrying mutations at W/c-kit or SI/MGF (SCF) Ioci. [Review]. Ann N Y Acad Sci 664:69-88, 1992
9. Geissler EN, Ryan MA, Housman DE: The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185-192, 1988
10. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically indudble TNF-alpha/cachectin. Nature 346:274-276, 1990
11. Gordon JR, Galli SJ: Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated vin the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174:103-107, 1991
12. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ: Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187:2045-2053, 1998a
13. Hart PH, Grimbaldeston MA, Swift GJ, Sedgwick D, Korner H, Finlay-Jones JJ: TNF modulates susceptibility to UVB-induced systemic immunomodulation in mice by effects on dermal mast cell prevalence. Eur J Immunol 28:2893-2901, 1998b
14. d mice. Blood 53:492-497, 1979
15. v mice and their increase by bone marrow transplantation. Blood 52:447-452, 1978
16. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614, 1990
17. Kurimoto I, Streilein JW: cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-α. J Immunol 148:3072-3078, 1992
18. Kurimoto I, Streilein JW: Studies of contact hypersensitivity induction in mice with optimal sensitizing doses of hapten. J Invest Dermatol 101:132-136, 1993
19. Kurimoto I, Streilein JW: Characterization of the immunogenetic basis of ultraviolet-B light effects on contact hypersensitivity induction. Immunology 81:352-358, 1994
20. Mekori YA, Galli SJ; Uudiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice. J Immunol 135:879-885, 1985
21. Nakamura T, Pinnel SR, Streilen JW: Vitamicin C abrogates the deleterious effects of UVB radiation on cutaneous immunity by a TNF-α independent mechanism. J Invest Dermatol 109:20-24, 1997
22. Nakano T, Sonoda T, Hayashi C, et al: Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162:1025-1043, 1985
23. Niizeki H, Alard P, Streilein JW: Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity. J Immunol 159:5183-5186, 1997
24. Schmidt CA, Furuta GT, Lavigne JA, Galli SJ, Wershil BK: The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol 171:140-146, 1996
25. Shimizu T, Streilein JW: Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 8:187-193, 1994
26. Tsai M, Shih LS, Newlands GF, et al: The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125-131, 1991
27. Vermeer M, Streilein JW: Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol, Photoimmunol Photomed 7:258-265, 1990
28. Vincek V, Kurimoto I, Medema JP, Prieto E, Streilein JW: Tumor necrosis factor alpha polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity. Cancer Res 53:728-732, 1993
29. Vincek V, Kurimoto I, Streilein JW: Polymorphism at the tumor necrosis factor-alpha locus and susceptibility to toxoplasmic encephalitis, ultraviolet B-induced immune impairment, and mouse AIDS [letter]. J Acquired Immune Deficiency Syndromes 7:734-735, 1994
30. Walsh L: Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-α. Immunol Cell Biol 73:226-233, 1995
31. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ: Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 154:1391-1398, 1995
32. Wille J, Njiehs F, Amin P, Kydonieus A: Topical delivery of mast cell degranulating agents for treatment of transdermal drug-induced hypersensitivity. Proc Intern Symp Controll Rel Bioact Mater 22:119-120, 1995
33. Yoshikawa T, Streilein JW: Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the TNF-α and Lps loci governs susceptibility. Immunogenetics 32:398-405, 1990
34. Yoshikawa T, Kurimoto I, Streilein JW: Tumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity. Immunology 76:264-271, 1992
35. Zsebo KM, Williams DA, Geissler EN, et al: Stem cell factor is encoded at the sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-224, 1990